285 related articles for article (PubMed ID: 25578962)
1. Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Sebestyén E; Zawisza M; Eyras E
Nucleic Acids Res; 2015 Feb; 43(3):1345-56. PubMed ID: 25578962
[TBL] [Abstract][Full Text] [Related]
2. The Functional Impact of Alternative Splicing in Cancer.
Climente-González H; Porta-Pardo E; Godzik A; Eyras E
Cell Rep; 2017 Aug; 20(9):2215-2226. PubMed ID: 28854369
[TBL] [Abstract][Full Text] [Related]
3. TSIS: an R package to infer alternative splicing isoform switches for time-series data.
Guo W; Calixto CPG; Brown JWS; Zhang R
Bioinformatics; 2017 Oct; 33(20):3308-3310. PubMed ID: 29028262
[TBL] [Abstract][Full Text] [Related]
4. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer.
Yang IS; Son H; Kim S; Kim S
BMC Genomics; 2016 Aug; 17(1):631. PubMed ID: 27519173
[TBL] [Abstract][Full Text] [Related]
5. Leveraging transcript quantification for fast computation of alternative splicing profiles.
Alamancos GP; Pagès A; Trincado JL; Bellora N; Eyras E
RNA; 2015 Sep; 21(9):1521-31. PubMed ID: 26179515
[TBL] [Abstract][Full Text] [Related]
6. IsoformSwitchAnalyzeR: analysis of changes in genome-wide patterns of alternative splicing and its functional consequences.
Vitting-Seerup K; Sandelin A
Bioinformatics; 2019 Nov; 35(21):4469-4471. PubMed ID: 30989184
[TBL] [Abstract][Full Text] [Related]
7. The Landscape of Isoform Switches in Human Cancers.
Vitting-Seerup K; Sandelin A
Mol Cancer Res; 2017 Sep; 15(9):1206-1220. PubMed ID: 28584021
[TBL] [Abstract][Full Text] [Related]
8. Identification of mRNA isoform switching in breast cancer.
Zhao W; Hoadley KA; Parker JS; Perou CM
BMC Genomics; 2016 Mar; 17():181. PubMed ID: 26939613
[TBL] [Abstract][Full Text] [Related]
9. Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer.
Li Y; Sahni N; Pancsa R; McGrail DJ; Xu J; Hua X; Coulombe-Huntington J; Ryan M; Tychhon B; Sudhakar D; Hu L; Tyers M; Jiang X; Lin SY; Babu MM; Yi S
Cell Rep; 2017 Oct; 21(3):798-812. PubMed ID: 29045845
[TBL] [Abstract][Full Text] [Related]
10. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.
Wang Z; Lo HS; Yang H; Gere S; Hu Y; Buetow KH; Lee MP
Cancer Res; 2003 Feb; 63(3):655-7. PubMed ID: 12566310
[TBL] [Abstract][Full Text] [Related]
12. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
13. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
14. Alternative transcription and alternative splicing in cancer.
Pal S; Gupta R; Davuluri RV
Pharmacol Ther; 2012 Dec; 136(3):283-94. PubMed ID: 22909788
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.
Li HR; Wang-Rodriguez J; Nair TM; Yeakley JM; Kwon YS; Bibikova M; Zheng C; Zhou L; Zhang K; Downs T; Fu XD; Fan JB
Cancer Res; 2006 Apr; 66(8):4079-88. PubMed ID: 16618727
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.
Tsai YS; Dominguez D; Gomez SM; Wang Z
Oncotarget; 2015 Mar; 6(9):6825-39. PubMed ID: 25749525
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
18. SplicePie: a novel analytical approach for the detection of alternative, non-sequential and recursive splicing.
Pulyakhina I; Gazzoli I; 't Hoen PA; Verwey N; den Dunnen JT; Aartsma-Rus A; Laros JF
Nucleic Acids Res; 2015 Jul; 43(12):e80. PubMed ID: 25800735
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer.
Hirschi B; Kolligs FT
Int J Cancer; 2013 Aug; 133(3):590-6. PubMed ID: 23354951
[TBL] [Abstract][Full Text] [Related]
20. Splice-mediated Variants of Proteins (SpliVaP) - data and characterization of changes in signatures among protein isoforms due to alternative splicing.
Floris M; Orsini M; Thanaraj TA
BMC Genomics; 2008 Oct; 9():453. PubMed ID: 18831736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]